Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,355 | 681 | 97.4% |
| Education | $211.17 | 9 | 2.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69.29 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $898.86 | 80 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $877.96 | 60 | $0 (2024) |
| Biogen, Inc. | $814.22 | 43 | $0 (2024) |
| UCB, Inc. | $632.81 | 35 | $0 (2024) |
| UPSHER-SMITH LABORATORIES LLC | $501.23 | 40 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $451.82 | 53 | $0 (2024) |
| Lundbeck LLC | $394.51 | 21 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $312.94 | 13 | $0 (2024) |
| EMD Serono, Inc. | $306.75 | 15 | $0 (2024) |
| Allergan, Inc. | $278.36 | 24 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,004 | 107 | ABBVIE INC. ($231.93) |
| 2023 | $1,588 | 91 | Biogen, Inc. ($238.66) |
| 2022 | $1,605 | 111 | Novartis Pharmaceuticals Corporation ($249.53) |
| 2021 | $1,307 | 88 | Biohaven Pharmaceuticals, Inc. ($217.02) |
| 2020 | $851.63 | 60 | Allergan, Inc. ($148.88) |
| 2019 | $1,798 | 142 | ACADIA Pharmaceuticals Inc ($170.91) |
| 2018 | $868.61 | 57 | ACADIA Pharmaceuticals Inc ($118.47) |
| 2017 | $613.21 | 37 | GENZYME CORPORATION ($49.30) |
All Payment Transactions
693 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.54 | General |
| 12/05/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: PAIN | ||||||
| 11/25/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $35.34 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: PAIN | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: PAIN | ||||||
| 10/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.43 | General |
| 10/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.84 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: EPILEPSY | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PAIN | ||||||
| 09/26/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Neurology | ||||||
| 08/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 235 | 267 | $60,967 | $19,179 |
| 2022 | 6 | 293 | 326 | $76,051 | $24,103 |
| 2021 | 7 | 338 | 362 | $83,026 | $28,408 |
| 2020 | 6 | 310 | 354 | $90,688 | $25,823 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 112 | $29,255 | $9,517 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $15,010 | $4,313 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 60 | $10,500 | $3,439 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,640 | $927.08 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 22 | $2,310 | $806.17 | 34.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 21 | $252.00 | $176.40 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 101 | $26,260 | $8,780 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $27,650 | $7,744 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 59 | $10,325 | $3,730 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $8,060 | $2,412 | 29.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 32 | $3,360 | $1,338 | 39.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 30 | 33 | $396.00 | $97.83 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 90 | $23,400 | $8,757 | 37.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 62 | 62 | $24,490 | $7,342 | 30.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 82 | $14,350 | $5,478 | 38.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 60 | 60 | $15,600 | $4,905 | 31.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 27 | 27 | $2,835 | $1,130 | 39.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 13 | $2,015 | $711.80 | 35.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 28 | 28 | $336.00 | $84.00 | 25.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 83 | 83 | $32,785 | $9,788 | 29.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 118 | $30,680 | $8,657 | 28.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 25 | 25 | $12,375 | $3,338 | 27.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 65 | $11,375 | $2,863 | 25.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 18 | 19 | $2,945 | $1,046 | 35.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 36 | 44 | $528.00 | $131.22 | 24.9% |
About Dr. Adam Jaffe, D.O
Dr. Adam Jaffe, D.O is a Neurology healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1740441286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Jaffe, D.O has received a total of $10,635 in payments from pharmaceutical and medical device companies, with $2,004 received in 2024. These payments were reported across 693 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($10,355).
As a Medicare-enrolled provider, Jaffe has provided services to 1,176 Medicare beneficiaries, totaling 1,309 services with total Medicare billing of $97,512. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Greensboro, NC
- Active Since 06/18/2008
- Last Updated 09/17/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1740441286
Products in Payments
- KESIMPTA (Drug) $555.85
- NURTEC ODT (Drug) $498.03
- QULIPTA (Drug) $490.25
- Briviact (Drug) $461.12
- NUPLAZID (Drug) $451.82
- UBRELVY (Drug) $383.65
- TYSABRI (Biological) $344.61
- VYEPTI (Biological) $323.63
- VUMERITY (Drug) $274.34
- BOTOX (Biological) $230.30
- ACTHAR (Biological) $227.74
- ZEPOSIA (Drug) $216.39
- APTIOM (Drug) $215.98
- ULTOMIRIS (Biological) $213.99
- EPIDIOLEX (Drug) $206.58
- Aimovig (Biological) $201.70
- TOSYMRA (Drug) $173.78
- AUBAGIO (Drug) $173.09
- MIGRANAL (Drug) $168.58
- ONPATTRO (Drug) $139.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Greensboro
Dr. Pramodkumar Sethi, M.d, M.D
Neurology — Payments: $69,973
Dr. Carmen Dohmeier, M.d, M.D
Neurology — Payments: $14,830
Yijun Yan, Md, MD
Neurology — Payments: $12,473
Saima Athar, M.d, Phd, M.D, PHD
Neurology — Payments: $9,443
Karen Aquino, M.d, M.D
Neurology — Payments: $9,199
Dr. Jindong Xu, Md, MD
Neurology — Payments: $8,447